1. Home
  2. JBGS vs DNA Comparison

JBGS vs DNA Comparison

Compare JBGS & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JBG SMITH Properties

JBGS

JBG SMITH Properties

BUY

Current Price

$11.65

Market Cap

823.7M

Sector

Real Estate

ML Signal

BUY

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

SELL

Current Price

$9.95

Market Cap

835.7M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
JBGS
DNA
Founded
2016
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
823.7M
835.7M
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
JBGS
DNA
Price
$11.65
$9.95
Analyst Decision
Sell
Sell
Analyst Count
3
3
Target Price
★ $12.00
$8.00
AVG Volume (30 Days)
786.9K
★ 3.3M
Earning Date
11-06-2026
11-09-2026
Dividend Yield
★ 6.05%
N/A
EPS Growth
N/A
★ 46.49
EPS
★ N/A
N/A
Revenue
★ $498,598,000.00
$170,155,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$2.61
$13.05
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$9.93
$5.37
52 Week High
$21.64
$18.22

Technical Indicators

Market Signals
Indicator
JBGS
DNA
Relative Strength Index (RSI) 59.67 47.32
Support Level $10.91 $6.54
Resistance Level $16.07 $11.12
Average True Range (ATR) 0.34 0.98
MACD 0.12 -0.38
Stochastic Oscillator 86.70 13.32

Price Performance

Historical Comparison
JBGS
DNA

About JBGS JBG SMITH Properties

JBG SMITH Properties is a real estate investment trust based in the United States. It owns, operates, invests in, and develops real estate assets concentrated in amenity-rich, metro-served submarkets in and around Washington, DC. In addition, the company also provides fee-based real estate services to legacy funds through its third-party real estate services business. The operating segments of the company are commercial, multifamily, and third-party real estate services. It generates maximum revenue from the commercial segment.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: